Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. So, whether you’re looking to pick up your very first editing suite or wanting to upgrade, double ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback